Academic Journal
What should be updated in the WHO guide to good prescribing?
| Τίτλος: | What should be updated in the WHO guide to good prescribing? |
|---|---|
| Συγγραφείς: | Hartjes MG; Department of Internal Medicine, Amsterdam UMC, location Vrije Universiteit Amsterdam, unit Pharmacotherapy, De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands. M.hartjes@amsterdamumc.nl.; Research and Expertise Centre in Pharmacotherapy Education (RECIPE), De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands. M.hartjes@amsterdamumc.nl.; Interprofessional Collaboration and Medication Safety, Faculty of Health, Sports and Social Work, InHolland University of Applied Sciences, Pina Bauschplein 4, Amsterdam, 1095 PN, The Netherlands. M.hartjes@amsterdamumc.nl., Hendriksen FMW; Department of Internal Medicine, Amsterdam UMC, location Vrije Universiteit Amsterdam, unit Pharmacotherapy, De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands.; Research and Expertise Centre in Pharmacotherapy Education (RECIPE), De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands., Bakkum MJ; Department of Internal Medicine, Amsterdam UMC, location Vrije Universiteit Amsterdam, unit Pharmacotherapy, De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands.; Research and Expertise Centre in Pharmacotherapy Education (RECIPE), De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands., Cazaubon Y; Pathogenesis and Control of Chronic and Emerging Infections (PCCEI), University of Montpellier, INSERM, Avenue du Doyen Gaston Giraud, Montpellier, 34090, France., Donker EM; Department of Internal Medicine, Amsterdam UMC, location Vrije Universiteit Amsterdam, unit Pharmacotherapy, De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands.; Research and Expertise Centre in Pharmacotherapy Education (RECIPE), De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands., van Leeuwen E; Department of Fundamental and Applied Medical Sciences, Ghent University, C. Heymanslaan 10, Ghent, 9000, Belgium., Likic R; Unit of Clinical Pharmacology, Department of Internal Medicine, University Hospital Centre Zagreb and University of Zagreb School of Medicine, 12 Kišpatićeva St, 10 000, Zagreb, Croatia., Pers YM; IRMB, University Montpellier, INSERM, CHU Montpellier, Montpellier, France., Phan TA; Department of Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Piët JD; Department of Internal Medicine, Amsterdam UMC, location Vrije Universiteit Amsterdam, unit Pharmacotherapy, De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands.; Research and Expertise Centre in Pharmacotherapy Education (RECIPE), De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands.; Interprofessional Collaboration and Medication Safety, Faculty of Health, Sports and Social Work, InHolland University of Applied Sciences, Pina Bauschplein 4, Amsterdam, 1095 PN, The Netherlands., De Ponti F; Department of Medical and Surgical Sciences, Pharmacology Unit, Alma Mater Studiorum, University of Bologna, Via Irnerio 48, Bologna, 40126, Italy., Raasch W; Institute of Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Lübeck, Germany., Richir MC; Department of Internal Medicine, Amsterdam UMC, location Vrije Universiteit Amsterdam, unit Pharmacotherapy, De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands.; Research and Expertise Centre in Pharmacotherapy Education (RECIPE), De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands.; Department of Surgery, University Medical Center Utrecht, Heidelberglaan 100, Utrecht, 3584 CX, The Netherlands., van Rosse F; Department of Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Rychlíčková J; Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech Republic., Sanz EJ; School of Medicine, Universidad de La Laguna, and Hospital Universitario de Canarias (SCS), Santa Cruz de Tenerife, La Laguna, Tenerife, 38071, Spain., Schwaninger M; Institute of Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Lübeck, Germany., Wallerstedt SM; Department of Pharmacology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Centre for Health Technology Assessment, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden., van Agtmael MA; Department of Internal Medicine, Amsterdam UMC, location Vrije Universiteit Amsterdam, unit Pharmacotherapy, De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands.; Research and Expertise Centre in Pharmacotherapy Education (RECIPE), De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands., Tichelaar J; Department of Internal Medicine, Amsterdam UMC, location Vrije Universiteit Amsterdam, unit Pharmacotherapy, De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands.; Research and Expertise Centre in Pharmacotherapy Education (RECIPE), De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands.; Interprofessional Collaboration and Medication Safety, Faculty of Health, Sports and Social Work, InHolland University of Applied Sciences, Pina Bauschplein 4, Amsterdam, 1095 PN, The Netherlands. |
| Πηγή: | European journal of clinical pharmacology [Eur J Clin Pharmacol] 2026 Oct 14; Vol. 82 (11). Date of Electronic Publication: 2026 Oct 14. |
| Τύπος έκδοσης: | Journal Article |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1041 (Electronic) Linking ISSN: 00316970 NLM ISO Abbreviation: Eur J Clin Pharmacol Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: Berlin, New York, Springer. |
| Ιατρικοί όροι (MeSH): | Drug Prescriptions*/standards , Practice Patterns, Physicians'*/standards , Pharmacology, Clinical*/education , Practice Guidelines as Topic*, Humans ; World Health Organization |
| Περίληψη: | Purpose: Over 30 years ago, the World Health Organization (WHO) published the Guide to Good Prescribing (GGP) with its accompanying six-step model for rational prescribing. While widely used and proven effective in teaching clinical pharmacology and therapeutics (CPT), the GGP has never been revised to reflect scientific, societal, technological, and educational developments. The aim of this study was to explore which elements could be revised to actualize its content. Methods: CPT teachers experienced with the GGP were recruited from all six WHO regions. Six online nominal group technique sessions were conducted to elicit and prioritize ideas for revising the GGP. Discussions were audio-recorded, transcribed verbatim, and analyzed using an inductive thematic approach to capture participants' views on both content and optimal format of the renewed GGP. Results: Twenty-six participants shared136 ideas for the revision, grouped into three main areas: ideas about the usability, accessibility, and awareness of the GGP; ideas about the six-step framework; and ideas about background information or supplementary chapters. Suggestions for improving usability emphasized an interactive, digital platform for accessibility, continuous updates, and integrated resources. Regarding the six-step model, participants recommended retaining its structure while incorporating key considerations such as pharmacovigilance, shared decision-making, and deprescribing. Lastly, participants proposed supplementary information on topics such as therapeutic reasoning and special patient populations. Conclusion: Suggestions for revising the WHO GGP included integrating contemporary and societal prescribing considerations to enhance its relevance, educational impact and usability, thereby supporting safe and effective prescribing in modern clinical practice. (© 2026. The Author(s).) |
| Competing Interests: | Declarations. Human ethics and consent to participate declarations: The Medical Ethics Review Committee of the Amsterdam University Medical Center determined that the study did not fall within the scope of the Medical Research Involving Human Subjects Act (WMO) (reference: 2022.0274). Informed consent was obtained in advance from all participants. Clinical trial number: Not applicable. Competing interests: The authors declare no competing interests. |
| References: | Br J Clin Pharmacol. 2016 Jul;82(1):280-4. (PMID: 26914983) Health Technol Assess. 1998;2(3):i-iv, 1-88. (PMID: 9561895) Clin Pharmacol Ther. 2019 Dec;106(6):1236-1245. (PMID: 31206612) Eur J Clin Pharmacol. 2023 Mar;79(3):341-348. (PMID: 36622428) Med Teach. 2017 Jan;39(1):14-19. (PMID: 27841062) Ann Fam Med. 2018 Nov;16(6):515-520. (PMID: 30420366) Drugs Aging. 2023 Dec;40(12):1085-1100. (PMID: 37863868) Eur Respir J. 2014 Oct;44(4):1055-68. (PMID: 25142482) J Am Med Inform Assoc. 2019 Oct 1;26(10):1141-1149. (PMID: 31206159) Int J Qual Health Care. 2007 Dec;19(6):349-57. (PMID: 17872937) Perspect Med Educ. 2023 Aug 30;12(1):348-360. (PMID: 37662713) Eur J Clin Pharmacol. 2020 Apr;76(4):507-513. (PMID: 31938856) Br J Clin Pharmacol. 2009 Jun;67(6):662-70. (PMID: 19594535) Lancet. 2023 Dec 16;402(10419):2346-2394. (PMID: 37977174) J Palliat Med. 2021 Dec;24(12):1867-1871. (PMID: 34726929) Med Sci Educ. 2020 Nov 16;31(1):273-289. (PMID: 34457882) Arch Intern Med. 2008 Sep 22;168(17):1890-6. (PMID: 18809816) Med Teach. 2020 Aug;42(8):846-854. (PMID: 32356468) J Interprof Care. 2021 Jul-Aug;35(4):612-621. (PMID: 31865823) Eur J Clin Pharmacol. 2022 Jul;78(7):1115-1126. (PMID: 35355082) Br J Clin Pharmacol. 2022 Mar;88(3):1334-1346. (PMID: 34505717) Eur J Clin Pharmacol. 2021 Aug;77(8):1209-1218. (PMID: 33624120) Br J Clin Pharmacol. 2012 Oct;74(4):621-31. (PMID: 22509885) NPJ Sci Learn. 2022 Sep 30;7(1):23. (PMID: 36180446) Environ Toxicol Chem. 2024 Mar;43(3):653-663. (PMID: 36647735) BMJ Open. 2025 Jul 25;15(7):e098052. (PMID: 40713041) BMJ Open. 2013 Aug 30;3(8):e003291. (PMID: 23996821) Lancet. 2025 Dec 13;406(10521):2804-2857. (PMID: 41175887) Int J Pharm Pract. 2026 Jun 8;34(3):321-324. (PMID: 42284070) Artif Intell Med. 2025 Apr;162:103089. (PMID: 39955846) BMC Med Educ. 2024 Nov 26;24(1):1360. (PMID: 39587582) |
| Grant Information: | 2022-1-NL01-KA220-HED-000088069 Erasmus+ |
| Contributed Indexing: | Keywords: Education; Medical education; Prescribing; Quality use of medicines |
| Entry Date(s): | Date Created: 20261014 Date Completed: 20261014 Latest Revision: 20261017 |
| Update Code: | 20261017 |
| PubMed Central ID: | PMC13668889 |
| DOI: | 10.1007/s00228-026-04198-1 |
| PMID: | 42873273 |
| Βάση Δεδομένων: | MEDLINE |
| ISSN: | 1432-1041 |
|---|---|
| DOI: | 10.1007/s00228-026-04198-1 |